Skip to main content
. 2014 Mar 4;110(8):1968–1976. doi: 10.1038/bjc.2014.72

Figure 2.

Figure 2

Patients' progression-free survival according to p95, PTEN, PI3K statuses in HER2-positive metastatic breast cancer.